Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier de Saint-Denis

About this trial

This study tests a new non-invasive device called DARE to monitor blood pressure in patients in intensive care. It compares the device's readings to standard invasive methods and also looks at how well it measures other vital signs like temperature, oxygen levels, and heart rhythm. The goal is to improve patient safety and comfort while helping doctors detect problems earlier.

Eligibility criteria

Qualifiers

Adult patients (male or female), aged 18 years or older

Admitted to intensive care unit (ICU) or critical care with an expected hospital stay longer than 2 days

Equipped with an arterial catheter for invasive blood pressure monitoring

Equipped with a urinary catheter for invasive core body temperature monitoring

Disqualifiers

Patients under 18 years old (minors)

Known skin allergy to adhesives or silicone, or skin condition preventing adhesive use

History of extensive skin pathology (e.g., Lyell syndrome)

Patients with therapeutic limitations

Trial design

Treatments tested in this trial

  • MultiSense® Non-Invasive Hemodynamic Monitoring Device

Treatment groups

2 Participants
are divided into 1 treatment group